Residential anxiety and OCD treatment for Miami — ERP density outpatient can't match.

For clients driving up from Brickell, Coral Gables, or Aventura, RECO Immersive sits about 65 minutes north on I-95 — close enough for weekly family sessions, far enough to interrupt the Miami-based social and nightlife triggers that sustain avoidance. Immersive runs disorder-specific tracks for OCD, panic disorder, GAD, and social anxiety with residential-density ERP, same-day SSRI titration under psychiatric supervision, and integrated management of comorbid depression. Most major PPO plans held by Miami-Dade employers are in-network.

From Brickell or Coral Gables, RECO Immersive’s Delray Beach campus is roughly 50 miles and 65 minutes north up I-95 — close enough for weekly family visits, far enough that most Miami-Dade clients live on-site through the program rather than commuting to daily therapy. For severe generalized anxiety disorder, panic disorder, social anxiety disorder, and OCD, that geographic separation from Miami’s social scene and nightlife triggers is part of the clinical rationale rather than incidental to it. This page describes what residential care at Immersive looks like for anxiety-primary presentations, and how admission from Miami-Dade typically proceeds.

Why residential anxiety treatment works when outpatient hasn’t

Outpatient cognitive-behavioral therapy — particularly exposure-based CBT — carries the strongest evidence base for every DSM anxiety disorder. Its structural weakness is that the exposures live in the space between sessions. A client learns a technique on Tuesday, is asked to run in-vivo exposures Wednesday through Friday, and returns Monday to review what happened. For clients whose baseline GAD-7 sits above 15 or whose Y-BOCS is 24 or higher, that between-session interval is the failure point: anxiety spikes at the moment of exposure, no clinician is available, avoidance wins, and the treatment plateaus.

Residential collapses that interval. Exposures can be run twice daily under direct staff coaching, with immediate individual and group processing when arousal peaks. For OCD, exposure and response prevention (ERP) delivered at residential density — 20 to 30 structured hours per week rather than one — produces meaningful Y-BOCS reduction on a weeks-rather-than-months timeline typical of once-weekly outpatient care.

The other reason severe presentations fail outpatient is functional load. A client who cannot leave the apartment, cannot tolerate a phone call, or is spending six hours a day on compulsions does not have the executive bandwidth to organize meals, sleep, and exposure homework simultaneously. Residential removes those loads so the clinical work can proceed.

OCD, panic, GAD, and social anxiety in the same building

The four primary anxiety disorders share medication logic — SSRIs at high dose — but the exposure protocols are disorder-specific. Immersive runs disorder-differentiated tracks rather than a single generic anxiety group.

OCD clients work an ERP protocol built from a subjective units of distress (SUDS) hierarchy, with response prevention monitored between exposures and Y-BOCS re-administered every two weeks. Panic disorder clients run interoceptive exposure — deliberate reproduction of the somatic symptoms (breath holds, hyperventilation, controlled spinning) that have become conditioned fear cues — alongside in-vivo exposure to avoided situations. Social anxiety clients work graded in-vivo hierarchies with behavioral experiments testing catastrophic predictions, often videotaped for post-exposure review. GAD clients work worry postponement, intolerance-of-uncertainty exercises, and metacognitive therapy targeting positive and negative beliefs about worry itself.

Acceptance and Commitment Therapy (ACT) is used across tracks for cognitive defusion and values-based behavioral activation. DBT distress tolerance and mindfulness skills are taught in mixed groups. Motivational interviewing (MI) is used to address ambivalence about exposure early in the stay.

SSRI optimization at anxiety-effective doses

Effective SSRI dosing for anxiety disorders typically sits at the upper end of the depression range, and higher still for OCD. Sertraline for GAD or panic is commonly optimized to 150-200 mg; escitalopram runs to 20 mg; paroxetine for OCD reaches 40-60 mg; fluoxetine for OCD 60-80 mg. Many clients arriving from Miami outpatient care are on subtherapeutic doses — 50 mg of sertraline, 10 mg of escitalopram — because titration was slowed by transient side effects or arrested at the first sign of partial response.

Residential structure allows faster titration under daily clinical observation. GI upset, activation, and sexual side effects are addressed as they emerge rather than at the next phone visit. Where SSRI monotherapy at optimized dose remains insufficient, augmentation is added with structured response tracking: buspirone for GAD, low-dose aripiprazole (2.5-5 mg) for OCD augmentation, mirtazapine for sleep-driven anxiety, and gabapentin or pregabalin in selected GAD presentations. Benzodiazepines are not used for maintenance treatment.

Comorbid depression and the sequenced treatment plan

Severe anxiety disorders present with comorbid major depression more often than not. The depression is frequently downstream — years of functional impairment, occupational loss, and social withdrawal driven by untreated anxiety produce a genuine major depressive episode that then complicates the diagnostic picture.

Immersive’s protocol names the primary diagnosis at admission — typically the anxiety disorder driving the impairment — and treats it first. PHQ-9 and GAD-7 or Y-BOCS are tracked weekly. In a substantial fraction of cases, effective anxiety treatment reduces PHQ-9 scores by 30-50% without a separate depression track, because the depressive symptoms were largely secondary. Where depression persists after anxiety severity has meaningfully declined, the plan is re-sequenced with SSRI augmentation, and in treatment-resistant cases, referral for rTMS at 3000 pulses per session at 120% of motor threshold or evaluation for esketamine.

What to expect in the first 72 hours

Admission begins with a psychiatric evaluation, medication reconciliation, and structured assessment — PHQ-9, GAD-7, Y-BOCS for OCD presentations, ASRS where ADHD is suspected, and MDQ where bipolar spectrum is on the differential. If alcohol or benzodiazepine use is part of the presentation, CIWA-Ar monitoring is initiated and medically supervised withdrawal is managed on-site before exposure work begins.

The first 72 hours prioritize sleep restoration, medication stabilization, and diagnostic clarity rather than rapid exposure. Clients are assigned a primary therapist, psychiatric provider, and case manager within 24 hours and a preliminary treatment plan is drafted. Formal exposure programming generally begins in week one, ramped by tolerance.

Insurance and admissions from Miami

Immersive is in-network with most major PPO plans held by Miami-Dade employers, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS out-of-state plans. Admissions completes benefits verification before intake and issues a written out-of-pocket estimate. Level-of-care justification is submitted to the payer under criteria consistent with ASAM Criteria dimensions — failed lower-level care, functional impairment, and clinical necessity for 24-hour structure — as documented in the intake for residential anxiety treatment.

For Miami-Dade clients, admissions coordinates ground transportation from Brickell, Coral Gables, Coconut Grove, Aventura, or Pinecrest, and from Miami International Airport for out-of-state family joining an intake. Family sessions begin the second week and are offered in person on campus or by secure video for family who cannot travel.

Serving residents of: Brickell, Coral Gables, Coconut Grove, Aventura, Pinecrest.